Close Menu

NEW YORK – Myriad Genetics reported after the close of the market on Thursday that its fiscal fourth quarter revenues declined 57 percent year over year.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.